Literature DB >> 21865020

Orchestrating the interferon antiviral response through the mitochondrial antiviral signaling (MAVS) adapter.

S Mehdi Belgnaoui1, Suzanne Paz, John Hiscott.   

Abstract

Sensing of RNA virus infection by the RIG-I-like receptors (RLRs) engages a complex signaling cascade that utilizes the mitochondrial antiviral signaling (MAVS) adapter protein to orchestrate the innate host response to pathogen, ultimately leading to the induction of antiviral and inflammatory responses mediated by type I interferon (IFN) and NF-κB pathways. MAVS is localized to the outer mitochondrial membrane, and has been associated with peroxisomes, the endoplasmic reticulum and autophagosomes, where it coordinates signaling events downstream of RLRs. MAVS not only plays a pivotal role in the induction of antiviral and inflammatory pathways but is also involved in the coordination of apoptotic and metabolic functions. This review summarizes recent findings related to the MAVS adapter and its essential role in the innate immune response to RNA viruses.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21865020     DOI: 10.1016/j.coi.2011.08.001

Source DB:  PubMed          Journal:  Curr Opin Immunol        ISSN: 0952-7915            Impact factor:   7.486


  111 in total

Review 1.  Emerging principles governing signal transduction by pattern-recognition receptors.

Authors:  Jonathan C Kagan; Gregory M Barton
Journal:  Cold Spring Harb Perspect Biol       Date:  2014-11-13       Impact factor: 10.005

2.  IκB kinase ε-dependent phosphorylation and degradation of X-linked inhibitor of apoptosis sensitizes cells to virus-induced apoptosis.

Authors:  Peyman Nakhaei; Qiang Sun; Mayra Solis; Thibault Mesplede; Eric Bonneil; Suzanne Paz; Rongtuan Lin; John Hiscott
Journal:  J Virol       Date:  2011-11-09       Impact factor: 5.103

Review 3.  Regulation of the mitochondrial proton gradient by cytosolic Ca²⁺ signals.

Authors:  Damon Poburko; Nicolas Demaurex
Journal:  Pflugers Arch       Date:  2012-04-24       Impact factor: 3.657

Review 4.  Architecture and biogenesis of plus-strand RNA virus replication factories.

Authors:  David Paul; Ralf Bartenschlager
Journal:  World J Virol       Date:  2013-05-12

5.  Viral degradasome hijacks mitochondria to suppress innate immunity.

Authors:  Ramansu Goswami; Tanmay Majumdar; Jayeeta Dhar; Saurabh Chattopadhyay; Sudip K Bandyopadhyay; Valentina Verbovetskaya; Ganes C Sen; Sailen Barik
Journal:  Cell Res       Date:  2013-07-23       Impact factor: 25.617

6.  Regulation of mitochondrial antiviral signaling (MAVS) expression and signaling by the mitochondria-associated endoplasmic reticulum membrane (MAM) protein Gp78.

Authors:  Jana L Jacobs; Jianzhong Zhu; Saumendra N Sarkar; Carolyn B Coyne
Journal:  J Biol Chem       Date:  2013-11-27       Impact factor: 5.157

Review 7.  MDA5 and LGP2: accomplices and antagonists of antiviral signal transduction.

Authors:  Kenny R Rodriguez; Annie M Bruns; Curt M Horvath
Journal:  J Virol       Date:  2014-05-21       Impact factor: 5.103

8.  Toll-like receptor 7 mediates early innate immune responses to malaria.

Authors:  Alyssa Baccarella; Mary F Fontana; Eunice C Chen; Charles C Kim
Journal:  Infect Immun       Date:  2013-09-16       Impact factor: 3.441

9.  Sustained activation of interferon regulatory factor 3 during infection by paramyxoviruses requires MDA5.

Authors:  Nathalie Grandvaux; Xiaochun Guan; Fabrice Yoboua; Nicolas Zucchini; Karin Fink; Priscilla Doyon; Lydie Martin; Marc J Servant; Stéfany Chartier
Journal:  J Innate Immun       Date:  2014-04-30       Impact factor: 7.349

10.  Structure and dynamics of the second CARD of human RIG-I provide mechanistic insights into regulation of RIG-I activation.

Authors:  Fabien Ferrage; Kaushik Dutta; Estanislao Nistal-Villán; Jenish R Patel; María T Sánchez-Aparicio; Pablo De Ioannes; Angeliki Buku; Gloria González Aseguinolaza; Adolfo García-Sastre; Aneel K Aggarwal
Journal:  Structure       Date:  2012-10-11       Impact factor: 5.006

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.